Table 3.
Specific monosaccharide linkages in HMO, BMO, and commercial oligosaccharides. Adapted from Kuntz et al. (2009)
| Glycans | Monosaccharide linkages |
|---|---|
| HMO | |
| Lacto-N-tetraose/hexaose/octaose/decaose | β1–3, β1–4, β1–6 |
| Fucosyllactose | α1–2, α1–3, α1–4, β1–3, β1–4 |
| Sialyllactose | α2–3, α2–6, β1–4 |
| Sialyl-lacto-N-tetraose | α2–3, α2–6, β1–3, β1–4 |
| BMO | |
| Acetyllactosamine | β1–4 |
| Galactosyllactose | β1–3, β1–4, β1–6 |
| Acetylneuraminyllactose (Neu5Ac) | α2–3, α2–6, α2–8, β1–4 |
| Glycolylneuraminyllactose (Neu5Gc) | α2–3, α2–6, β1–4 |
| Galactooligosaccharides (GOS) | α1–2, α1–4, α1–6 |
| Fructooligosaccharides (FOS) | β1–2 |